A B S T R A C T Thyroxine-binding prealbumin (TBPA) in normal human serum has been shown in a polyacrylamide gel electrophoresis system to bind 7-9% of tracer level purified ['I] 
INTRODUCTION
Thyroxine-binding prealbumin (TBPA)1 in human serum was first described in electrophoretic studies by Ingbar (1) . Prealbumins which bind thyroxine (T4) are also present in certain animal sera (2) (3) (4) . It has been generally acknowledged that human TBPA does not bind triiodothyronine (T3) (5) (6) (7) (8) (9) . Recent emphasis on the metabolic importance of serum T3 (10) (11) (12) , coupled with our own observations that animal serum prealbumin may bind T3 (13) , caused us to investigate T3 binding in human serum using previously described polyacrylamide gel electrophoresis methods (4, 14) . We find that TBPA in normal human serum can indeed be shown electrophoretically to bind T3.
METHODS
Sera. Sera were obtained from three healthy euthyroid adult male subjects (N. B., R. S., P. D.) and from male patients with no immunologically demonstrable thyroxinebinding globulin (TBG) (J. W.) or with low TBG levels (G. G.).' Sera were also obtained from four additional normal adults and pooled for certain studies at pH 7.4. Hypothyroxinemic serum (0.1 ug thyroxine (T4) per 100 ml, by column chromatography) was available from a patient with untreated primary hypothyroidism (D. S.). All sera were stored at -17'C until used.
Radioactive hormones, chemicals, and biological materials.
[125J]T4 was obtained from Abbott Laboratories (North Chicago, Ill.). It contained 91% T4 in a silica gel thinlayer chromatography (TLC) system (n-butanol: acetone: methanol: 2N NH4OH) and was used without further purification. [ 'SI]T3 was purchased from the same commercial source and was purified before use on Sephadex LH-20 columns (Pharmacia Fine Chemicals Inc., Piscataway, N. J.) (15) . Purity of the labeled T3 eluted was verified in a tate; T3, triiodothyronine; T4, thyroxine; TBG, thyroxinebinding globulin; TBPA, thyroxine-binding prealbumin; TETRAC, tetraiodothyroacetic acid; TLC, thin-layer chromatography.
'TBG radioimmunoassays per-formed by Dr. R. P. Levy. TBG  min  TBPA  TBG  min  TBPA   N. B.  16  400  Control  46  34  9  43  15  35  MK-185  22  47  21  19  14  60  TETRAC  41  39  10  49  21  23  Salicylate  51  35  7  62  17  15  R. S.  16  189  Control  54  29  9  42  14  36  MK-185  41  38  12  30  13  52  TETRAC  45  36  11  53  18 Table I ). Data presented in this manner indicate, for example, that MK-185 competes with T3 for sites on TBG and displaces T3 to albumin and TBPA. In the presence of MK-185, TBG bound (0.76 X 71) or 54% of tracer T3. Small salicylate and TETRAC effects on the T3-TBPA interaction are suggested by these data; however, the absolute change in amount T3 bound by TBPA in the presence of salicylate or TETRAC at pH 7.4 is comparable to the negligible change at pH 9.0 (Table I) .
sodium phosphate, pH 9 .0. The slabs were polymerized in a Plexiglas cell (E-C Apparatus Corp., Philadelphia, Pa.) from 2 vol 20% Cyanogum-41 (Fisher Scientific Co., Pittsburgh, Pa.) with 2 vol tetramethylethylenediamine 1% in 0.02 M sodium phosphate, pH 9.0, and 1 vol ammonium persulfate 0.15%. The reservoir buffer was 0.025 m sodium phosphate, pH 9.0, and was circulated during electrophoresis. The conditions of the electrophoresis were 130 v, 100 ma, 5°C for 5 hr. Before and after electrophoresis the pH of the reservoir buffer and of the gel buffer (macerated gel samples) was measured. After electrophoresis the gel buffer pH decreased by 0.4-0.6 U whereas reservoir buffer pH was unchanged. Reservoir buffer was discarded after a single run. After electrophoresis the gels were dried flat (4) and radioautographed for 2-10 days. The gels were then superimposed on radioautographs and zones of T3 or T4 binding were cut out of the gels and counted in a well-type scintillation counter. Radioactivity was also quantitated in zones between the electrophoretic origin and TBG, between albumin and TBPA, and between TBPA and a point 3 cm anodal to TBPA ("unbound hormone") (4). All experiments were performed twice, and data reported are means of determinations of replicate experiments. TBG maximum binding capacities (MBC) and TBPA MBC were measured at T4 concentrations in serum of 100 #g/100 ml and 600 1Ag/100 ml, respectively, in the pH 9.0 polyacrylamide gel electrophoresis system. An adjunctive series of electrophoretic experiments was carried out in agarose (General Biochemicals, Div., Chagrin Falls, Ohio), made up 1% in 0.03 M or 0.05 M sodium phosphate buffer, pH 8.6. Experiments were run at 100 v, 120 ma at 5°C for 100 min in vertical gel slabs. There was no alteration in reservoir buffer pH after electrophoresis; gel buffer pH was 8.0-8.2 after each run.
After electrophoresis the gels were dried and radioautographed as described for the polyacrylamide gel systems.
Purified TBPA. Studies of T3 and T4 binding by purified human TBPA were conducted by adding purified TBPA to cow serum in an amount constituting a TBPA concentration of 75 mg/100 ml in the serum. Radioactive T3 or T4 was then added to this mixture and to cow serum, (17, 18) , displaced T3 from TBG to albumin and TBPA at pH 7.4 (Table II) . These data are expressed as per cent control binding (4, 19) to facilitate recognition of sites of competition and redistribution of displaced hormone; control binding data, i.e. distribution of radioiodothyronines before addition of inhibitors, are cited in the footnote to Table II. At pH 9.0 the addition of MK-185 to normal serum caused from 12-22% of tracer T3 to be bound by TBPA (Table I) . Salicylate (20) and TETRAC (19) are known to complete with T4 for binding sites on TBPA (actions which are verified in our electrophoretic systems in the tracer T4 data shown in Tables I  and II) , but neither salicylate nor TETRAC had consequential effects on T3-TBPA interaction. In the case of the TBG-deficient serum studied, salicylate also failed to affect TBPA binding of T4 (J. W., Table I ).
Effects of loading of unlabeled T4 and T3 on [ Additions of unlabeled T3 (up to 800 ,ig/100 ml) to pooled sera containing radioactive T4 did not displace labeled T4 from TBPA.
Binding of T3 and T4 by purified human serum TBPA. Electrophoresis of mixtures of purified TBPA and radioactive hormones in buffer resulted in diffuse TBPA and unbound hormone bands. Because cow serum contains no TBPA (2), it was selected as a suitable carrier in which purified TBPA might be subjected to electrophoresis and its ability to bind T3 verified. Fig. 4 shows that [fI]T3 and ['I]T4 are bound in discrete bands by TBPA, whereas there is no T3 or T4 binding anodal to cow serum albumin when cow serum has not been enriched with TBPA. Measured radioautographically, the apparent electrophoretic mobility of cow serum albumin was slightly, but consistently, slower in the presence of radioactive T3 than with radioactive T4 (Fig. 4) . Stained for protein with 0.1% amido black, however, cow serum containing 2000 ,g/100 ml unlabeled T3 or T4 showed the albumin band to be of precisely the same mobility and width.
DISCUSSION
Contrary to a number of previous reports, the electrophoretic experiments described here indicate that TBPA in normal human serum binds a significant fraction of tracer T3 and that in sera which do not contain TBG, or which contain a competitive inhibitor of TBG binding, TBPA may bind large amounts of T3. Confirmatory electrophoretic evidence is supplied by the demonstration of T3 binding by purified human TBPA. These electrophoretic data are in accord with recent studies by Larsen in which binding of T3 by purified TBPA has been shown in ultrafiltration experiments or inferred from ultrafiltration studies of whole serum containing binding inhibitors (21) .' The addition of unlabeled T4 to serum containing ['I]T3 (Figs. 2, 3 ) displaced T3 from TBG to TBPA and albumin and, interestingly, eventuated in only minimal displacement of T3 from TBPA even when the T4 level in serum was raised to saturation levels for T4 binding by TBPA (600-800 ,g T4/100 ml). Progressive loading of serum with unlabeled T3, however, resulted in T3 displacement from TBPA (and from TBG) to albumin.
Displacement studies carried out with additions of salicylate or TETRAC to pooled sera confirmed that these agents competed with T4 for binding sites on TBPA (19, 20) , but failed to show interference with TBPA binding of T3. These observations, together with the differential effects of loading of serum with unlabeled T3 or T4, raise the possibility that T3 and T4 interactions with TBPA may not occur at the same site, although other explanations for these findings are possible (for example, existence of heterogeneous species of prealbumins would account for differences in T3 and T4 binding, or T3 interaction with TBPA could have allosteric consequences which prevent competitive T4 interaction with the T3-TBPA complex). The interaction of TBPA and the retinol-binding protein (RBP)-vitamin A complex occurs at a site different from that of T4 binding by TBPA (22) . It is apparent from Table I that the expected effect of salicylate on T4-TBPA interaction failed to occur in the TBG-deficient serum which was studied (J. W.). This observation was verified when the initial (replicate) studies were subsequently repeated. The addition of TETRAC to J. W.'s serum also failed to affect T4 binding by TBPA. The intriguing possibility that TBPA in this TBG-deficient serum was functionally distinct from TBPA in normal serum could not be further investigated because of unavailability of additional serum from subject J. W.
It was essential in the present studies that purified T3 be used since commercially available radiotriiodothyronine is often contaminated with radiothyroxine which would misleadingly indicate small amounts of "T3" binding by TBPA. This possibility was excluded in our studies since the ['I]T3 used was purified by 'Larsen, P. R. Personal communication. Triiodothyronine-Prealbumin Interaction petition between electrophoretic medium and serum proteins for thyroid hormone occurs; in the case of T3, media other than polyacrylamide gel may be more effective binders of the hormone than is TBPA. Our own studies of T3 distribution in serum in another electrophoretic medium (agarose), using phosphate buffer, failed to demonstrate discrete TBPA binding of T3. With the experience of others with starch and paper media, the agarose gel results emphasize that polyacrylamide has certain properties which permit the electrophoretic observation of T3-TBPA interaction. Differences in electrophoretic buffer, responsible for the initial failure to recognize prealbumin binding of T4 (1), do not explain previous inability to document T3 binding by TBPA, since phosphate buffer, used here, has been utilized in other media where T3 binding by TBPA was not observed.
Previous reports that T3 may, under certain conditions, migrate in the P-globulin zone on electrophoresis (23, 24) , as well as with TBG and albumin, could not be confirmed in our studies. It is also apparent that T3 distribution among serum proteins does not simply reflect T4 distribution (although binding proteins have a greater affinity for T4), since our T4-loading studies showed T3 to be displaced to TBPA, but only minimally dislodged from TBPA by very high serum T4 concentrations. In addition, hypothyroxinemic serum (D. S., Table I ) showed the same TBPA binding of T3 as did normal serum.
The physiological significance of T3 binding by TB-PA remains to be elucidated. Despite the binding of small but significant amounts of T3 by TBPA in normal sera, the presence of TBG, with a higher affinity for T3 than TBPA, would minimize alterations in T3-TBPA interaction (i.e., T3 displaced from TBPA should be bound by TBG, not remain in the unbound state). Thus, changes in TBPA concentration in the blood should not in normal subjects greatly affect the level of free T3. Interference in vivo with T3 binding -by TBPA through the clinical use of inhibitors of TBPA binding also should not affect free T3 in serum. However, in the TBG-deficient subject, or in the clinical situation in which an inhibitor of TBG binding is present in the blood, alteration in T3 economy could conceivably derive from changes in TBPA concentration.
